Page 47 - Biomedical Engineering and Design Handbook Volume 2, Applications
P. 47

26  MEDICAL DEVICE DESIGN

                               Class I          Class II                   Class III
                               Low risk         Moderate risk              High risk
                               General controls  General controls/special controls  General controls
                               Exempt           510(k)                     PMA

                               FIGURE 2.3 Medical device class hierarchy.

                         Congress decided to control this wide range of medical devices by a classification system.
                       A hierarchy of three classes was established (Fig. 2.3).
                         Note that the classes are always referenced by their Roman numerals, for example, Class III
                       medical devices.
                         The classes are risk based, with Class I being the lowest risk and Class III the highest. The statu-
                       tory definitions are as follows:
                         Class III
                         (C) Class III, Premarket Approval.—A device which because—
                            (i) it
                                (I) cannot be classified as a Class I device because insufficient information exists to determine
                                  that the application of general controls are sufficient to provide reasonable assurance of the
                                  safety and effectiveness of the device, and
                               (II) cannot be classified as a Class II device because insufficient information exists to determine
                                  that the special controls described in subparagraph (B) would provide reasonable assurance
                                  of its safety and effectiveness, and
                            (ii)
                                (I) is purported or represented to be for a use in supporting or sustaining human life or for a
                                  use which is of substantial importance in preventing impairment of human health, or
                               (II) presents a potential unreasonable risk of illness or injury,
                         is to be subject, in accordance with section 360e of this title, to Premarket Approval to provide reasonable
                         assurance of its safety and effectiveness.
                         If there is not sufficient information to establish a performance standard for a device to provide reason-
                         able assurance of its safety and effectiveness, the Secretary may conduct such activities as may be neces-
                         sary to develop or obtain such information.
                         (2) For purposes of this section and sections 360d and 360e of this title, the safety and effectiveness of a
                            device are to be determined—
                            (A) with respect to the persons for whose use the device is represented or intended,
                            (B) with respect to the conditions of use prescribed, recommended, or suggested in the labeling of
                               the device, and
                            (C) weighing any probable benefit to health from the use of the device against any probable risk of
                               injury or illness from such use.
                         (3)
                            (A) Except as authorized by subparagraph (B), the effectiveness of a device is, for purposes of this
                               section and sections 360d and 360e of this title, to be determined, in accordance with regulations
                               promulgated by the Secretary, on the basis of well-controlled investigations, including 1 or more
                               clinical investigations where appropriate, by experts qualified by training and experience to eval-
                               uate the effectiveness of the device, from which investigations it can fairly and responsibly be
                               concluded by qualified experts that the device will have the effect it purports or is represented to
                               have under the conditions of use prescribed, recommended, or suggested in the labeling of the
                               device.
                            (B) If the Secretary determines that there exists valid scientific evidence (other than evidence derived
                               from investigations described in subparagraph (A))—
                               (i) which is sufficient to determine the effectiveness of a device, and
                               (ii) from which it can fairly and responsibly be concluded by qualified experts that the device
                                 will have the effect it purports or is represented to have under the conditions of use pre-
                                 scribed, recommended, or suggested in the labeling of the device,
   42   43   44   45   46   47   48   49   50   51   52